CNTB:NASDAQ, Connect Biopharma Holdings Limited

CNTB stock overview

Connect Biopharma Holdings Limited (CNTB:NASDAQ) closed at $0.781 on November 4, 2026, up 0.83% on the day. The stock trades 79.6% below its 52-week high of $3.82 and 6.6% above its 52-week low of $0.732. Over the past year, it lost 53.0%. Connect Biopharma Holdings Limited is part of the Health Care sector.

Key figures

Price: $0.781
Day change: +0.83%
Volume: 299,071
Average volume: 3,991,714
Market cap: 49M+
52-week range: $0.732 – $3.82
50-day average: $1.30
200-day average: $2.18

Price action over the past year

In 252 trading sessions since November 4, 2025, CNTB closed higher on 117 days (46%). Its best day was November 14, 2025 (+26.19%) and its worst was September 15, 2026 (-32.17%). The stock moved 10% or more in a single session 18 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

Nov 5, 2026: Trading sideways between $0.767 and $0.849 over 14 days (Sideways scanner)
Sep 3, 2026: Spiked to $2.93 on 3M+ shares (Spikes scanner)
Sep 3, 2026: Dropped 30.1% in a single session (Dips & Crashes scanner)

CNTB news

About Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307, CBP-174, and CBP-233.

Similar stocks

Find more stocks like CNTB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.